AHA GUIDELINES Bundle (free trial)

Stable Ischemic Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/102913

Contents of this Issue

Navigation

Page 26 of 45

25 Diabetes Management Î For selected individual patients, such as those with a short duration of diabetes mellitus and a long life expectancy, a goal hemoglobin A1c (HbA1c) of ≤7% is reasonable. (IIa-B) Î A goal HbA1c between 7% and 9% is reasonable for certain patients according to age, history of hypoglycemia, presence of microvascular or macrovascular complications, or presence of coexisting medical conditions. (IIa-C) Î Initiation of pharmacotherapy interventions to achieve target HbA1c might be reasonable. (IIb-A) Î Therapy with rosiglitazone should NOT be initiated in patients with SIHD. (III-C: Harm) Physical Activity Î For all patients, the clinician should encourage 30-60 minutes of moderate-intensity aerobic activity, such as brisk walking, at least 5 days and preferably 7 days per week, supplemented by an increase in daily lifestyle activities (eg, walking breaks at work, gardening, household work) to improve cardiorespiratory fitness and move patients out of the least-fit, least-active, high-risk cohort (bottom 20%). (I-B) Î For all patients, risk assessment with a physical activity history and/or an exercise test is recommended to guide prognosis and prescription. (I-B) Î Medically supervised programs (cardiac rehabilitation) and physician- directed, home-based programs are recommended for at-risk patients at first diagnosis. (I-A) Î It is reasonable for the clinician to recommend complementary resistance training at least 2 days per week. (IIa-C) Weight Management Î BMI and/or waist circumference should be assessed at every visit, and the clinician should consistently encourage weight maintenance or reduction through an appropriate balance of lifestyle physical activity, structured exercise, caloric intake, and formal behavioral programs when indicated to maintain or achieve a BMI between 18.5 and 24.9 kg/m 2 and a waist circumference <102 cm (40 inches) in men and <88 cm (35 inches) in women (less for certain racial groups). (I-B) Î The initial goal of weight loss therapy should be to reduce body weight by ~5% to 10% from baseline. With success, further weight loss can be attempted if indicated. (I-C)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Stable Ischemic Heart Disease